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Abstract
Stimulation of human epithelial cells with IL-1 (10 ng/ml) + UVB radiation results in sustained NFB activation
caused by continuous IKKb phosphorylation. We have recently published a strictly reduced ordinary differential
equation model elucidating the involved mechanisms. Here, we compare model extensions for low IL-1 doses (0.5
ng/ml), where delayed IKKb phosphorylation is observed. The extended model including a positive regulatory
element, most likely auto-ubiquitination of TRAF6, reproduces the observed experimental data most convincingly.
The extension is shown to be consistent with the original model and contains very sensitive processes which may
serve as potential intervention targets.
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Introduction
The transcription factor NFB is of central importance in
inflammation and anti-apoptotic signaling. Upon stimu-
lation of human epithelial cells with IL-1, NFB becomes
activated due to proteasomal degradation of its cellular
inhibitor IBa. This process requires phosphorylation of
IBa by the upstream kinase IKKb. Since sustained
NFB-dependent expression of anti-apoptotic genes con-
tributes to the maintenance of a range of cancers, its
activity is tightly regulated and terminated by a negative
feedback loop, as NFBp r o m o t e sI Ba synthesis.
Accordingly, various approaches to anti-cancer strategies
involve inhibition of the NFB signaling pathway [1].
Interestingly, NFB is converted into a pro-apoptotic
factor upon stimulation with IL-1 + UVB. The persistence
of this effect is ensured by sustained NFB activity [2]
caused by sustained phosphorylation of IKKb resulting in
instant phosphorylation and proteasomal degradation of
newly synthesized IBa.C h r o n i cI K K b phosphorylation,
in turn, is due to UVB-induced inhibition of the responsi-
ble phosphatase PP2Ac [2]. We investigated the details of
these processes using a systems biological approach, lead-
ing to the following ordinary differential equation model
of IKKb phosphorylation and dephosphorylation [3]:
[I˙ LR] = −il(t) · ka[ILR]
[I˙ LRc] = il(t) · ka[ILR] − ki[ILRc]
[I˙ KKp] = kp[kin][IKK] − kdp[PP2A][IKKp]
[P˙ P2A] = −uv(t) · kuv[PP2A]
(1)
with [ILR](0) = 1, [ILRc](0) = 0, [IKKp](0) = 0, [PP2A](0)
= 1, [IKK] = 1 - [IKKp]. By western blot analysis, we mea-
sure IKKp_obs = IKKp scale_IKK. The factor scale_IKK
describes the unknown ratio between the strength of the
IKKp band on the gel and the concentration of IKKp.
The system variables describe the normalized concen-
trations of IL-1 receptor [ILR], IL-1 receptor complex
[ILRc], phosphorylated and unphosphorylated IKKb
([IKKp] and [IKK]), and PP2Ac [PP2A], the inputs il(t)
and uv(t) describe IL-1 concentration and UVB radiation.
Due to the normalization, all kinetic parameters of this
model are given in s
-1 except for ka (nM
-1 s
-1), since il(t)
is given in nM.
In the original model [3] the effects of the signaling
cascade are considered to be negligible, so that the
IKKb kinase [kin] is assumed to have the same time
course as [ILRc], i.e., [kin] = [ILRc]. Despite this simpli-
fying assumption the model works well for high IL-1
doses (10 ng/ml, corresponding to 0.588 nM), indicating
that the simplification is justified in this dose range.
While IKKb is very rapidly phosphorylated upon
10 ng/ml IL-1 stimulation, delayed IKKb phosphoryla-
tion could be observed upon 0.5 ng/ml or 0.029 nM
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provided the original work is properly cited.IL-1 stimulation (Figure 1). This slowly increasing phos-
phorylation activity is only insufficiently reproduced by
the original model, so that a more detailed model of the
signaling cascade appears appropriate for low IL-1
doses. However, the mechanism causing the signal delay
is unknown to date. In principle, various reasons for sig-
nal delay are conceivable. Among the most prominent
examples are double phosphorylation as occurring, e.g.,
in the MAPK cascade [4], mechanisms with irreversible
inhibitors and positive feedback mechanisms. Here we
will investigate these three mechanisms by extending
the original model by each of them separately to predict
the most probable explanation for the delay.
Modeling
Each of the three potential mechanisms delaying the sig-
naling cascade following low doses of IL-1 is modeled as
a separate building block (see Figure 2). It is then used
to calculate [kin] as a function of [ILRc], where [kin] is
[Tu] or [Ypp] or [Xa], depending on the potential
mechanism (see below).
The positive feedback mechanism describes the auto-
catalyzed activation of a protein T to the activated form
Tu. This mechanism is given as
[˙ Tu] = ku[ILRc][T] + kaut[ILRc][T][Tu] − kdu[Tu] (2)
with [Tu](0) = 0 and [T] = 1 - [Tu].
In the double phosphorylation mechanism, the active
form Ypp of a protein Y is reached after two sequen-
tial modifications (e.g., phosphorylations) catalyzed by
ILRc:
[˙ Yp] = kyp1[ILRc][Y] − kydp1[Yp] − kyp2[ILRc][Yp] + kydp2[Ypp]
[˙ Ypp] = kyp2[ILRc][Yp] − kydp2[Ypp]
(3)
with [Y] = 1 - [Yp] - [Ypp], [Yp](0) = 0, [Ypp](0) = 0.
In the irreversible inhibitor mechanism, an irreversible
inhibitor I blocks the activated form Xa of some protein
X within the signaling cascade. The mechanism is
implemented as
[˙ X] = −kact[ILRc][X] + kdact[Xa]
[˙ Xa] = kact[ILRc][X] − kdact[Xa] − kinh[Xa][I]
[˙ I] = −kinh[Xa][I]
(4)
where [X](0) = 1, [Xa](0) = 0, [I](0) = I0. Note that [I]
can also be obtained from the mass conservation
relation [I] = [X] + [Xa] + I0 - 1. All concentrations
except [I] are scaled without loss of generality so that all
non-zero initial concentrations except I0 are 1 (see the
analogous argumentation in Additional File 1 of [3]).
The exception of [I] is due to the term kinh [Xa][I]
which occurs in the differential equations for both [˙ Xa]
and [˙ I] Figure 2 shows a schematic representation of the
original model and the three extensions.
While no specific irreversible inhibitor mechanism is
known within the IL-1 signaling cascade, the double
phosphorylation mechanism might, e.g., correspond to
IRAK-1 or IRAK-4 phosphorylation [5]. A promising
candidate for the positive feedback mechanism in the
IL-1 signaling cascade is TRAF6: The E3-ligase TRAF6
is a key mediator of IL-1 induced signaling because its
auto-ubiquitination is required to activate IKKb [6].
Hence, the positive feedback mechanism might describe
TRAF6 auto-ubiquitination. In the following, we there-
fore refer to this model extension as the TRAF exten-
sion. Note that, while no other comparable mechanism
is known to date within the IL-1 signalling cascade, the
TRAF module might also represent a different, yet
unknown positively auto-regulated mechanism within
the signalling cascade.
Experimental data for 0.5 ng/ml IL-1 stimulation were
obtained from three western blot experiments measur-
ing IKKb Ser177/181 phosphorylation in human epithe-
lial carcinoma cell line KB following IL-1 stimulation
with and without UVB (300 J/m
2) costimulation until
120 min post-stimulation as described in [3]. They were
subsequently extended with data from two western blots
covering the first 30 min after IL-1 stimulation without
UVB. Data for the 10 ng/ml IL-1 ± UVB stimulation are
taken from [3]. Maximal IKKb phosphorylation was
clearly lower for low (0.5 ng/ml) than for high (10 ng/
ml) IL-1 stimulation, so that the maximal value could
not be used as a reference value for scaling. Therefore, a
separate scaling factor was used for IKKb following 0.5
and 10 ng/ml IL-1 stimulation.
Modeling and analysis was performed with the Matlab
(The MathWorks) based software tool PottersWheel
(http://www.potterswheel.de freely available for aca-
demic use) [7], analogously to the procedures described
in [3]. Particularly, the c
2 value was used as objective
function, with
χ2(θ)=
M 
i=1
Ni 
j=1
(yij − y(tij, θ))
2
σij
2
where M is the number of stimulations (i.e., M =4 ) ,
Ni is the number of data points under stimulation i, yij
is data point j under stimulation i with standard devia-
tion sij and y(tij, θ) is the simulated value at time point j
under stimulation i for the parameter vector θ.
Figure 1 IKKb phosphorylation is delayed following stimulation
with 0.5 ng/ml IL-1 (adapted from [3]).
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mulations was set to 4, as obtained from experimental
data (not shown). Upper bounds for the remaining para-
meter values were derived as described in [3], lower
bounds were not required.
Results and Discussion
Comparison of the different model extensions
Fitting of the model with its different extensions to the
experimental data yields better c
2 values than the origi-
nal model for all extensions (Table 1). Comparison of
the parameter values with the parameter values of the
original model showed that the parameters downstream
of the model extension, i.e., kuv, kp, and kdp, remain basi-
cally unchanged (Table 2).
While all model extensions are able to reproduce the
delay (Figure 3; Figures S1 and S2 in Additional file 1),
t h eT R A Fe x t e n s i o ni st h em o d e ls t r u c t u r ew i t ht h e
least degrees of freedom and lowest c
2 value. Conse-
quently, it also yields the best (lowest) value of the Cor-
rected Akaike InformationC r i t e r i o n ,A I C c ,w h i c h
compares the goodness-of-fit of models with a different
number of parameters (Table 1). In contrast, the other
extensions only perform about as well as the original
model in terms of AICc.
The TRAF extension convincingly reproduces the
experimental data and especially the signal delay (Figure
3), and a biological counterpart to this mechanism exists
within the IL-1 signaling cascade. In the following, we
therefore focus on the TRAF extension. All parameter
values of this extension are given in Table S1 in Addi-
tional file 1.
Detailed analysis of the TRAF6 model extension
Fixing of all model parameters also occurring in the ori-
ginal model to their value reported in [3] yields only
slightly worse fit quality of c
2 = 24.3. Remarkably, the
fit quality is still better than the fit quality of the origi-
nal model [3] (c
2 =2 4 . 5 ) ,w h e r eo n l yt h ed a t as e t sf o r
IKKp IKK
ILR ILRc
IL-1
ka
ki
kp
kdp
PP2A
kuv UV
Model Extension
Xa X
kact
kdact
I kp kinh
Yp Y kyp1
kydp1
kp
Ypp kyp2
kydp2
T Tu ku
kaut
kdu
kp
ILRc
ILRc
a) b)
c) d)
ILRc
Figure 2 Graphical representation of the four model variants. Schematic representation of the original IKKb phosphorylation model (a) with
the extensions positive feedback/TRAF (b), double phosphorylation (c), and irreversible inhibitor (d). Ellipses denote model inputs, boxes with
solid lines denote state variables, boxes with dotted lines denote species calculated from mass conservation relations. Normal arrows denote
mass flows, circles at an arrow tail signify that the reactant participates catalytically in the reaction.
Table 1 c
2 values and AICc of the model and its
extensions fitted to the four experimental data sets
Model c
2 value AICc
Original (a) 45.8 124.9
TRAF (b) 23.1 113.7
Double phosphorylation (c) 28.3 123.5
Irreversible inhibitor (d) 27.0 122.2
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Page 3 of 610 ng/ml IL-1 doses ±UVB are considered. As to the
time course, the most prominent difference of the
model extension compared to the original model con-
sists in a longer plateau phase of the maximum concen-
trations, which is in better agreement to the measured
data. In summary, the model extension is consistent to
the model presented in [3] and justifies its additional
complexity with a considerable enhancement of the fit
quality and a consistent qualitative behavior for low
doses.
Although the parameter fixing performed above sug-
gests that identifiability in the extended model might be
worse than in the original one, identifiability analysis
shows that all parameter values are identifiable from the
given data: 2000 fits were performed with initial para-
meter values obtained by randomly perturbing the best
parameter values by up to four orders of magnitude.
The standard deviation of the parameter sets of the best
800 fits is not more than 1% for each parameter.
Furthermore, we calculated the relative sensitivity
si =
∂x/x
∂pi/pi
of x against perturbations in parameter pi following IL-
1 stimulation for two time-independent characteristics x
Table 2 Values of the kinetic parameters downstream of
the model extension in the original model [3] and in the
extended models
Model kp (s
-1) kdp (s
-1) kuv (s
-1)
Original (a) 0.095 7.6e-4 2.4e-4
TRAF (b) 0.095 9.3e-4 2.6e-4
Double phos. (c) 0.095 7.5e-4 2.3e-4
Irr. inhibitor (d) 0.095 7.2e-4 2.3e-4
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Figure 3 IKKb phosphorylation following different stimulations - experimental data and simulation results of the model with TRAF
extension. Columns show stimulation with IL-1 or IL-1 + UVB (300 J/m
2) radiation, respectively, applied at t = 0 s. Rows indicate whether a high
(10 ng/ml) or low (0.5 ng/ml) IL-1 dose was applied. A different scaling factor is chosen for the data for 10 and 0.5 ng/ml IL-1 stimulation.
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Page 4 of 6of IKKp(t): the IKKp peak amplitude, x =m a x ( I K K p ( t))
and the mean of IKKp within the longest observed time
period,
x =
1
2.75h
2.75h 
0h
IKKp(t)d t
For both sensitivity measures, a high dose dependency
can be observed (Figure 4): for 10 ng/ml (0.588 nM) IL-
1, parameter perturbations result in relatively weaker
changes of the mean IKKp value (|si|<1 ) ,a n dh a v e
almost no effect on the peak amplitude. In contrast, the
system is quite sensitive upon 0.5 ng/ml (0.029 nM) IL-
1 stimulation: for several parameters, perturbations have
an amplified effect on both peak amplitude and average
IKKp value (|si| > 1). Furthermore, the system is sensi-
tive over a wide dose range, with sensitivities of up to
±5 (Figure 4).
Taken together, the positive feedback regulation pre-
sumably mediated via TRAF6 auto-ubiquitination [6]
represents a consistent, well identifiable extension of the
IKKb phosphorylation model that reproduces the time
delay at low IL-1 stimulations and is in accordance with
literature findings.
On the other hand, it should be noted that determina-
tion of low levels of phosphorylated IKKb is an experi-
mentally challenging task, so that the values for 0.5 ng/
ml IL-1 stimulation should be regarded as somewhat
semiquantitative measurements despite the partially low
standard deviation. Against this background, though the
postulated model consistently explains the experimental
data one should neither completely reject the other two
investigated mechanisms, which also perform well, nor
lose sight of other potential delay mechanisms. Never-
theless, our results may provide an indication that the
reported TRAF6 auto-ubiquitination [6] can indeed be
interpreted as a positive feedback loop.
The very good accordance of the relatively small
model with the experimental data together with the
reported findings [6] make TRAF6 auto-ubiquitination a
promising candidate for further research. Several system
parameters could be characterized as very sensitive at
low IL-1 doses. The respective processes therefore qua-
lify as potential intervention targets in cancer therapy.
The systems biological approach in combination with
the necessary experimental validation can help to
further elucidate important molecular mechanisms.
Additional material
Additional file 1: Figure S1. IKKb phosphorylation following
different stimulations - experimental data and simulation results of
the model with buffer extension. Columns show stimulation with IL-1
or IL-1 + UVB (300 J/m
2) radiation, respectively, applied at t = 0 h. Rows
indicate whether a high (10 ng/ml) or low (0.5 ng/ml) IL-1 dose was
applied. A different scaling factor is chosen for the data for 10 and 0.5
ng/ml IL-1 stimulation. Figure S2. IKKb phosphorylation following
different stimulations - experimental data and simulation results of the
model with double phosphorylation extension. Columns show
stimulation with IL-1 or IL-1 + UVB (300 J/m
2) radiation, respectively,
applied at t = 0 h. Rows indicate whether a high (10 ng/ml) or low (0.5
ng/ml) IL-1 dose was applied. A different scaling factor is chosen for the
data for 10 and 0.5 ng/ml IL-1 stimulation. Table S1. Parameter values of
the model with TRAF extension Supplemental table
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factor 6.
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